Side-by-side comparison of AI visibility scores, market position, and capabilities
Cairo Egypt's first online insurance broker with eKYC and digital issuance; $4.76M EBRD and YC-backed achieving 14x distribution partnership growth in Egypt's $2B insurance market with 20%+ annual growth.
Amenli is Cairo-based Egypt's first fully licensed online insurance broker — providing consumers and small businesses with transparent, digital-first insurance products across health, auto, property, travel, and life categories through a platform that integrates eKYC, eSignatures, and end-to-end digital policy issuance into a fully paperless insurance purchasing experience. Founded in 2020 and backed with $4.76 million raised including a $2.3 million round led by the European Bank for Reconstruction and Development (EBRD) and Y Combinator in November 2024, Amenli achieved 14x year-over-year growth in retail distribution partnerships operating in Egypt's $2 billion insurance market growing at 20%+ annually.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.